Fadi Khir

Fadi Khir

Auto-generated profile, based on publicly available information

Fadi Khir

Internal Medicine Residency Program, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2021 in Rheumatology International
Verified
Journal Article
Open access
PDF file
MNMostafa Najim
Mostafa Najim
ARAlaa Rahhal
Alaa Rahhal
FKFadi Khir
Fadi Khir
AAAmer Hussien Aljundi
Amer Hussien Aljundi
SASafae Abuyousef
Safae Abuyousef
SASamar A. Alemadi
Samar A. Alemadi
Coronavirus disease 2019 (COVID-19) increases the risk of coagulopathy. Although the presence of antiphospholipid antibodies (aPLs) has been proposed as a possible mechanism of COVID-19-induced coagulopathy, its clinical significance remains uncertain. Therefore, this study aimed to evaluate the prevalence and clinical significance of aPLs among critically ill patients with COVID-19. This prospective observational study included 60 patients with COVID-19 admitted to intensive care units (ICU). The study outcomes included prevalence of aPLs, and a primary composite outcome of all-cause mortality and arterial or venous thrombosis between antiphospholipid-positive and antiphospholipid-negative patients during their ICU stay. Multiple logistic regression was used to assess the influence of aPLs on the primary composite outcome of mortality and thrombosis. A total of 60 critically ill patients were enrolled. Among them, 57 (95%) were men, with a mean age of 52.8 ± 12.2 years, and the majority were from Asia (68%). Twenty-two patients (37%) were found be antiphospholipid-positive; 21 of them were positive for lupus anticoagulant, whereas one patient was positive for anti-β2-glycoprotein IgG/IgM. The composite outcome of mortality and thrombosis during their ICU stay did not differ between antiphospholipid-positive and antiphospholipid-negative patients (4 [18%] vs. 6 [16%], adjusted odds ratio 0.98, 95% confidence interval 0.1–6.7; p value = 0.986). The presence of aPLs does not seem to affect the outcomes of critically ill patients with COVID-19 in terms of all-cause mortality and thrombosis. Therefore, clinicians may not screen critically ill patients with COVID-19 for aPLs unless deemed clinically appropriate.

19 April 2020 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
ARAlaa Rahhal
Alaa Rahhal
FKFadi Khir
Fadi Khir
MAMohammad Adam
Mohammad Adam
AAAmer Aljundi
Amer Aljundi
MMMohammed Khalil Mohsen
Mohammed Khalil Mohsen
JSJassim Al Suwaidi
Jassim Al Suwaidi
Background: Combined oral contraceptive pills are associated with an established risk for venous thrombosis; however, their risk for arterial thrombosis remains uncertain, especially with the development of low dose new generations of combined oral contraceptive. Arterial thrombosis is less likely to occur with the use of oral contraceptive pills in the absence of cardiovascular risk factors. Case presentation: We report a 35-year old female with no cardiovascular risk factors who presented with thrombotic anterior wall myocardial infarction 6 months after using a third generation low dose combined oral contraceptive pills (Marvelon; ethinylestradiol 30 mcg and desogestrel 150 mcg). Conclusion: Third generation low dose combined oral contraceptives may lead to myocardial infarction in young women, even in the absence of other cardiovascular risk factors.

29 June 2021 in Cureus
Verified
Journal Article
Open access
ACAmmar Farook Chapra
Ammar Farook Chapra
FKFadi Khir
Fadi Khir
AAAns Abdualla Ali Alamami
Ans Abdualla Ali Alamami
KSKhaled M. Salem
Khaled M. Salem
AYAlhady Yusof
Alhady Yusof
Systemic lupus erythematosus (SLE) is a disease that affects multiple systems in the body. Due to its variable manifestations, it can at times pose challenges for physicians to hold SLE as the culprit behind an affected system. This is most true when encountering patients with neuropsychiatric manifestations of SLE. We present a case of a 38-year-old female with known SLE limited to skin involvement and on treatment for active pulmonary tuberculosis (TB), yet otherwise healthy, who presented with acute fever associated with generalized tonic-clonic seizures. She was investigated for meningoencephalitis with a cerebrospinal fluid (CSF) analysis not being fully conclusive and with imaging features suggestive of viral encephalitis. However, despite receiving optimal care for causes of bacterial, viral, and tuberculous meningitis the patient continued to deteriorate and started to develop predominant psychiatric symptoms in the form of confusion and combative behavior requiring pharmacological restraint. Hence a trial of immunosuppressives was given with a presumptive diagnosis of neuropsychiatric lupus with IV methylprednisolone followed by a course of IV cyclophosphamide. However, this treatment proceeded with caution due to the fear of disseminated tuberculosis for which she did not show any sign of in the subsequent weeks. The patient showed modest clinical and radiological improvement and hence the treatment was continued. The case highlights the uncertainty that may precede a diagnosis of neuropsychiatric lupus and the challenges in treating it in patients with active mycobacterial infection.

17 October 2020 in British Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
ARAlaa Rahhal
Alaa Rahhal
FKFadi Khir
Fadi Khir
AAAmer Hussien Aljundi
Amer Hussien Aljundi
YAYaser AlAhmad
Yaser AlAhmad
HAHakam Alzaeem
Hakam Alzaeem
AAAbdul Rahman Arabi
Abdul Rahman Arabi

1 July 2021 in Journal of Electrocardiology
Verified
Journal Article
Open access
FKFadi Kazahia Khir
Fadi Kazahia Khir
NBNaim Ghazi Battikh
Naim Ghazi Battikh
AAAbdul Rahman Arabi
Abdul Rahman Arabi
Chest pain is still representing one of the most common and serious presentations to the emergency department worldwide. ECG is a crucial tool in evaluating patients with chest pain; however, only around 50% of patients with acute coronary syndrome (ACS) will have a diagnostic ECG upon their presentation; the rest may either have a completely normal ECG or what is called nonspecific ST segment and T wave (NSSTTW) changes, hence it is essential to recognize the subtle ECG changes and know its significance. One of the ECG changes that can be easily missed is when the T wave in V1 is upright, especially when it is either a Tall Upright T wave (TTV1) or a New Tall Upright T-wave (NTTV1). Although upright T wave in lead V1 can be a normal variant, it has been linked in a few studies and observations to cardiovascular disease, especially myocardial ischemia. In this article, we are trying to highlight the importance of this subtle ECG change in predicting cardiovascular disease through a concise review of the available evidence on this topic.